These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 20504921)
1. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921 [TBL] [Abstract][Full Text] [Related]
2. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253 [TBL] [Abstract][Full Text] [Related]
3. Impaired Nef function is associated with early control of HIV-1 viremia. Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA J Virol; 2014 Sep; 88(17):10200-13. PubMed ID: 24965469 [TBL] [Abstract][Full Text] [Related]
4. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. Miura T; Brockman MA; Brumme ZL; Brumme CJ; Pereyra F; Trocha A; Block BL; Schneidewind A; Allen TM; Heckerman D; Walker BD J Virol; 2009 Jan; 83(1):140-9. PubMed ID: 18971283 [TBL] [Abstract][Full Text] [Related]
5. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731 [TBL] [Abstract][Full Text] [Related]
6. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles. Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762 [TBL] [Abstract][Full Text] [Related]
7. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations. Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617 [TBL] [Abstract][Full Text] [Related]
8. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232 [TBL] [Abstract][Full Text] [Related]
9. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection. Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528 [TBL] [Abstract][Full Text] [Related]
10. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57. Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088 [TBL] [Abstract][Full Text] [Related]
11. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945 [TBL] [Abstract][Full Text] [Related]
12. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112 [TBL] [Abstract][Full Text] [Related]
13. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes. Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R mBio; 2017 Nov; 8(6):. PubMed ID: 29184023 [TBL] [Abstract][Full Text] [Related]
14. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers. Brumme ZL; Li C; Miura T; Sela J; Rosato PC; Brumme CJ; Markle TJ; Martin E; Block BL; Trocha A; Kadie CM; Allen TM; Pereyra F; Heckerman D; Walker BD; Brockman MA J Acquir Immune Defic Syndr; 2011 Feb; 56(2):100-8. PubMed ID: 21124229 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses. Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797 [TBL] [Abstract][Full Text] [Related]
16. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044 [TBL] [Abstract][Full Text] [Related]
17. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function. Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081 [TBL] [Abstract][Full Text] [Related]
18. Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. Schneidewind A; Tang Y; Brockman MA; Ryland EG; Dunkley-Thompson J; Steel-Duncan JC; St John MA; Conrad JA; Kalams SA; Noel F; Allen TM; Christie CD; Feeney ME J Virol; 2009 Sep; 83(17):8616-27. PubMed ID: 19515764 [TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control. Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008 [TBL] [Abstract][Full Text] [Related]
20. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV. Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]